Beiley Biofund Inc. (TPEX: 7882)
Financials · Capital Markets · TW
NT$23.90
+0.84% today · +3.2% 1Y
Beiley Biofund Inc. (TPEX: 7882) operates in the Capital Markets industry within the Financials sector. The company is valued at $153.34M.
Over the last twelve months the share price has gained 3.2%, trading between 17.60 and 33.55.
Tweenvest scores Beiley Biofund Inc. across four factors: quality 59/100, value 67/100, dividend 92/100. Its strongest factor is dividend.
7882 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $153.34M
- Revenue (TTM)
- $39.08M
- P/E
- 4.36
- EPS
- 5.48
- Dividend yield
- 5.86%
- Beta (5Y)
- —
- 52-week high
- NT$33.55
- 52-week low
- NT$17.60
- Avg volume (3M)
- —
- Shares outstanding
- 205.28M
- Employees
- —
- Next earnings
- —
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.32T | $377.07 | -0.31% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $701.83 | -0.27% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $889.41B | $767.13 | -0.28% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $817.93B | $763.47 | -0.29% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $480.69B | $706.32 | -1.00% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.66B | $86.93 | -0.65% |
| Morgan StanleyNYSE: MS | $336.23B | $214.08 | -0.06% |
| The Goldman Sachs Group, Inc.NYSE: GS | $313.75B | $1,036.28 | -0.29% |
Figures last refreshed Aug 18, 2026.